A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.
Ulrich-Pur H, Kornek GV, Raderer M, Haider K, Kwasny W, Depisch D, Greul R, Schneeweiss B, Krauss G, Funovics J, Scheithauer W.
Ulrich-Pur H, et al. Among authors: kornek gv.
Cancer. 2000 Jun 1;88(11):2505-11. doi: 10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co;2-e.
Cancer. 2000.
PMID: 10861426
Clinical Trial.